175 related articles for article (PubMed ID: 35614037)
1. Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.
Brandolini L; d'Angelo M; Novelli R; Castelli V; Giorgio C; Sirico A; Cocchiaro P; D'Egidio F; Benedetti E; Cristiano C; Bugatti A; Ruocco A; Amendola PG; Talarico C; Manelfi C; Iaconis D; Beccari A; Quadros AU; Cunha TM; Caruso A; Russo R; Cimini A; Aramini A; Allegretti M
Cell Death Dis; 2022 May; 13(5):500. PubMed ID: 35614037
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy.
Cristiano C; Giorgio C; Cocchiaro P; Boccella S; Cesta MC; Castelli V; Liguori FM; Cuozzo MR; Brandolini L; Russo R; Allegretti M
Cytokine; 2023 Nov; 171():156370. PubMed ID: 37722320
[TBL] [Abstract][Full Text] [Related]
3. Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.
Kyte SL; Toma W; Bagdas D; Meade JA; Schurman LD; Lichtman AH; Chen ZJ; Del Fabbro E; Fang X; Bigbee JW; Damaj MI; Gewirtz DA
J Pharmacol Exp Ther; 2018 Jan; 364(1):110-119. PubMed ID: 29042416
[TBL] [Abstract][Full Text] [Related]
4. Methods and protocols for chemotherapy-induced peripheral neuropathy (CIPN) mouse models using paclitaxel.
Pennypacker SD; Fonseca MM; Morgan JW; Dougherty PM; Cubillos-Ruiz JR; Strowd RE; Romero-Sandoval EA
Methods Cell Biol; 2022; 168():277-298. PubMed ID: 35366987
[TBL] [Abstract][Full Text] [Related]
5. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
7. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
[TBL] [Abstract][Full Text] [Related]
8. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
[TBL] [Abstract][Full Text] [Related]
10. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy.
Itoh K; Shimoyama M; Schiller PW; Toyama S
Chem Biol Drug Des; 2023 Apr; 101(4):1012-1018. PubMed ID: 36513390
[TBL] [Abstract][Full Text] [Related]
12. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
15. Comparative Transcriptome of Dorsal Root Ganglia Reveals Distinct Etiologies of Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy in Rats.
Sun W; Hao Y; Li R; Ho IHT; Wu S; Li N; Ba X; Wang J; Xiong D; Jiang C; Xiao L; Liu X
Neuroscience; 2023 Apr; 516():1-14. PubMed ID: 36822350
[TBL] [Abstract][Full Text] [Related]
16. Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis.
Spera MC; Cesta MC; Zippoli M; Varrassi G; Allegretti M
Pain Ther; 2022 Dec; 11(4):1113-1136. PubMed ID: 36098939
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2.
Cho HS; Choi YI; Park SU; Han YS; Kwon J; Jung SJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768178
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy.
Chen LH; Yeh YM; Chen YF; Hsu YH; Wang HH; Lin PC; Chang LY; Lin CK; Chang MS; Shen MR
Pain; 2020 Jun; 161(6):1237-1254. PubMed ID: 32068666
[TBL] [Abstract][Full Text] [Related]
19. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
[TBL] [Abstract][Full Text] [Related]
20. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
